BMJ Covid-19: Fourth vaccine doses—who needs them and why? ... around a quarter of immunosuppressed patients still had no responses after three doses"

BMJ Covid-19: Fourth vaccine doses—who needs them and why? ... around a quarter of immunosuppressed patients still had no responses after three doses" submitted by /u/shallah
[link] [comments] https://ift.tt/Zq3aDUh March 04, 2022 at 01:40AM https://ift.tt/FQaMiKu

LA County's Mask Mandate Could End For Everyone, Regardless Of Vaccination Status, As Soon As Friday

LA County's Mask Mandate Could End For Everyone, Regardless Of Vaccination Status, As Soon As Friday
LA County's Mask Mandate Could End For Everyone, Regardless Of Vaccination Status, As Soon As Friday submitted by /u/Exastiken
[link] [comments]
https://ift.tt/CGiSboR March 02, 2022 at 08:22AM https://ift.tt/hPAsbjD

AstraZeneca inks $760 mln deal with Swiss firm Neurimmune for antibody drug

AstraZeneca inks $760 mln deal with Swiss firm Neurimmune for antibody drug ASTRAZENECA-NEURIMMUNE/ (URGENT, PIX)AstraZeneca inks $760 mln deal with Swiss firm Neurimmune for antibody drug https://ift.tt/U1DKPmz

Pfizer vaccine effective against severe COVID-19 for children between 5 and 11, CDC says

Pfizer vaccine effective against severe COVID-19 for children between 5 and 11, CDC says submitted by /u/Exastiken
[link] [comments]


source https://www.reddit.com/r/Health/comments/t4l86s/pfizer_vaccine_effective_against_severe_covid19/

Pfizer vaccine effective against severe COVID-19 for children between 5 and 11, CDC says

Pfizer vaccine effective against severe COVID-19 for children between 5 and 11, CDC says
Pfizer vaccine effective against severe COVID-19 for children between 5 and 11, CDC says submitted by /u/Exastiken
[link] [comments]
https://ift.tt/gv4VExh March 02, 2022 at 04:42AM https://ift.tt/hPAsbjD

Pfizer vaccine effective against severe COVID-19 for children between 5 and 11, CDC says

Pfizer vaccine effective against severe COVID-19 for children between 5 and 11, CDC says submitted by /u/Exastiken
[link] [comments]